A Double-blind, Randomized, Placebo Controlled Single Site Study to Evaluate the Effects of Evolocumab (AMG 145) Treatment Alone and in Combination with Atorvastatin on Lipoprotein Kinetics
- Barrett, Hugh (Chief Investigator)
- Watts, Gerald (Investigator 02)